- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Atazanavir with cobicistat – November 2015
Atazanavir with cobicistat: atazanavir 300 mg + cobicistat 150 mg; fixed dose combination tablets 30; Evotaz®
Last updated
4 March 2016